Abstracts

HIV Prevention 2.0: What’s Next?

For the first 30 years of the HIV epidemic, the 3 pillars of the prevention of sexual HIV transmission focused on HIV education, testing, and condoms. These interventions, tied to community mobilization campaigns, led to dramatic declines in HIV transmission in many communities. Substantial disparities remain in HIV incidence in vulnerable populations, particularly among men…

Pathogenesis of HIV Complications

While HIV-infected individuals with access to modern antiretroviral therapy (ART) have experienced a dramatic improvement in life expectancy, they remain at higher risk than the general population for morbidity and mortality, particularly from non-AIDS complications typically associated with aging. While lifestyle factors (e.g., smoking, illicit drug use, obesity, etc) as well as ART toxicities likely…

HIV Cure Research

Although current antiretroviral therapy suppresses HIV replication and halts the otherwise inevitable progression to AIDS, it is not curative. Even after a decade or more, its interruption leads inevitably to reappearance of the virus within a few weeks. These results imply the existence of a “reservoir” of HIV-infected cells capable of producing infectious virus that…

Martin Delaney Presentation: How to End the HIV Epidemic: Community Perspectives

Moderator: Steven F. Wakefield, HIV Vaccine Trials Network, Fred Hutch, Seattle, WA, USA Topics and Panel Members: Pre-exposure Prophylaxis (PrEP): Damon L. Jacobs, LMFT, New York New York, USA Treatment as Prevention (TasP): Connie L. Celum, MD, MPH, University of Washington, Seattle, WA, USA Cure-Related Research: Matt Sharp, Project Inform, San Francisco, CA, USA Background:…

Getting SMART About Innovative Designs for Studying Effectiveness: The Case of Adaptive Implementation Interventions

The effective treatment and management of a wide variety of health disorders, including HIV/AIDS, often requires individualized, sequential decision-making. To do this, each patient’s treatment is dynamically adapted over time based on the patient’s history and changing disease state. Adaptive interventions (also known as dynamic treatment regimens) operationalize individualized decision making using a sequence of…

The Clinical Pharmacology of Medication Adherence

Recognizing that suboptimal adherence is the major cause of treatment failure and lack of effectiveness of ARVs for PrEP, scalable interventions to improve adherence are badly needed. However, there are multiple patterns of suboptimal adherence and an understanding of the definitions and taxonomy of adherence is essential in designing interventions (Vrijens et al., Br J…

Epidemiological and Biostatistical Issues in Studying Rare Events in HIV

Studies of rare events have advanced scientific understanding of HIV prevention, treatment, and pathogenesis. While the definition of what is considered ‘rare’ is subjective, examples include individuals who: Remain free of HIV despite persistent high exposure; Acquire HIV in prevention studies & populations with low incidence; Exhibit extremes of disease progression: rapid disease progression, long-term…

Measuring Immunity 1 Cell at a Time

The immune system is comprised of incredibly diverse sets of cells, each programmed to carry out overlapping sets of effector functions. Quantifying any one function provides an incomplete view of the immune response, as information about what other responses are generated is absent. Quantifying multiple responses is far superior, but when carried out on a…

Studying Heterogeneity With Single Cell RNA-Sequencing

Heterogeneity is a complicated problem to study. In many contexts, researchers use purified or cultured cells, treating them as a uniform population, while often a certain degree of heterogeneity is present. Treated in bulk, the large amount of individual will allow the buffering of extreme phenotypes. Heterogeneity is often suspected, but the means of exploring…

Integration-Site Analysis

The lecture will cover analysis of HIV DNA integration sites in model systems, in HIV infected patients, and in human gene therapy. Methods: With the development of efficient methods for DNA sequence acquistion, it has become possible to study the geomic locations of populations of integrated proviruses. Results: Early studies showed that HIV favors integration…